TNYA's three largest insider shareholders as of September 29, 2026 are David V Goeddel (Director, 49.31Mn shares), David V Goeddel (Director, 9.87Mn shares), Group Iii Gp, Lp Column (TenPercentOwner, 9.87Mn shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | David V Goeddel | Director, TenPercentOwner | 0 | 49,313,559 | 49,313,559 | 73.6% | 07 Mar, 2025 |
| 2 | Group Iii Gp, Lp Column | TenPercentOwner | 0 | 9,870,274 | 9,870,274 | 14.7% | 23 Jan, 2023 |
| 3 | Eli Casdin | Director | 0 | 6,078,860 | 6,078,860 | 9.1% | 25 Nov, 2022 |
| 4 | Faraz Ali | Chief Executive Officer | 539,782 | 0 | 539,782 | 0.8% | 11 Sep, 2026 |
| 5 | Deepak Srivastava | Director | 0 | 372,435 | 372,435 | 0.6% | 09 Dec, 2022 |
| 6 | Whittemore Tingley | Chief Medical Officer | 263,073 | 0 | 263,073 | 0.4% | 11 Sep, 2026 |
| 7 | Timothy Hoey | Chief Scientific Officer | 245,346 | 0 | 245,346 | 0.4% | 06 Mar, 2024 |
| 8 | Tomohiro Higa | Svp, Finance | 118,267 | 0 | 118,267 | 0.2% | 19 May, 2026 |
| 9 | Leone D Patterson | Chief Fin. And Bus. Officer | 95,755 | 0 | 95,755 | 0.1% | 27 Feb, 2024 |
| 10 | Chihiro Saito | Svp, Accounting And Fin. Ops. | 60,983 | 0 | 60,983 | 0.1% | 18 Nov, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 10 Sep, 2026 | Faraz Ali | Chief Executive Officer | Acquired A | 122,000 | $0.00 | $0 | 539,782 | Direct |
| 10 Sep, 2026 | Whittemore Tingley | Chief Medical Officer | Acquired A | 49,000 | $0.00 | $0 | 263,073 | Direct |
| 10 Sep, 2026 | Faraz Ali | Chief Executive Officer | Acquired A | 732,500 | $0.00 | $0 | 732,500 | Direct |
| 10 Sep, 2026 | Whittemore Tingley | Chief Medical Officer | Acquired A | 293,000 | $0.00 | $0 | 293,000 | Direct |
| 17 Aug, 2026 | Faraz Ali | Chief Executive Officer | Disposed S | 5,837 | $0.71 | $4.14K | 434,177 | Direct |
| 17 Aug, 2026 | Whittemore Tingley | Chief Medical Officer | Disposed S | 1,637 | $0.71 | $1.16K | 219,860 | Direct |
| 17 Aug, 2026 | Faraz Ali | Chief Executive Officer | Disposed S | 3,969 | $0.71 | $2.82K | 430,208 | Direct |
| 17 Aug, 2026 | Whittemore Tingley | Chief Medical Officer | Disposed S | 1,637 | $0.71 | $1.16K | 218,223 | Direct |
| 17 Aug, 2026 | Whittemore Tingley | Chief Medical Officer | Disposed S | 1,871 | $0.71 | $1.33K | 216,352 | Direct |
| 17 Aug, 2026 | Faraz Ali | Chief Executive Officer | Disposed S | 5,020 | $0.71 | $3.56K | 425,188 | Direct |
| 17 Aug, 2026 | Faraz Ali | Chief Executive Officer | Disposed S | 7,406 | $0.71 | $5.26K | 417,782 | Direct |
| 17 Aug, 2026 | Whittemore Tingley | Chief Medical Officer | Disposed S | 2,279 | $0.71 | $1.62K | 214,073 | Direct |
| 13 Jul, 2026 | Eric J Hyllengren | Chief Financial Officer | Acquired A | 1,650,000 | $0.00 | $0 | 1,650,000 | Direct |
| 28 May, 2026 | June Lee | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 28 May, 2026 | Amy L. Burroughs | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 28 May, 2026 | Jeffrey T. Walsh | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 28 May, 2026 | Deepak Srivastava | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 28 May, 2026 | R Sanders Williams | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 28 May, 2026 | Catherine Stehman-Breen | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |
| 28 May, 2026 | Karah Herdman Parschauer | Director | Acquired A | 120,000 | $0.00 | $0 | 120,000 | Direct |